Skip to main content
. 2022 Jun 30;25(2):106–113. doi: 10.3831/KPI.2022.25.2.106

Table 2.

Results based on the weight of the experimental studied groups

Groups Total number of live births Weight of live births
Means ± SD


Male + Female Male Female Male + Female Male Female
C1 61 31 30 5.85 ± 0.75 6.04 ± 0.70 5.64 ± 0.76
T1 28 14 14 6.29 ± 0.47 6.43 ± 0.44 6.15 ± 0.47
T2 11 5 6 3.38 ± 0.59 3.27 ± 0.55 3.47 ± 0.66
C2 67 31 36 4.02 ± 0.66 3.95 ± 0.76 4.08 ± 0.57
T3 76 41 35 4.07 ± 1.10 4.12 ± 1.26 4.15 ± 0.91
T4 38 18 20 2.23 ± 0.82 2.57 ± 0.28 1.91 ± 1.02

C1: Control group that received no medication. T1: Treated groups receiving 365 mg/kg starting from first day of insemination. T2: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy. C2: Control group that received no medication and underwent caesarian section on the 15th day of gestational age. T3: Treated groups receiving 365 mg/kg starting from first day of insemination and underwent caesarian section on the 15th day of gestational age. T4: Treated groups receiving 365 mg/kg starting from 30 days prior to pregnancy and underwent caesarian section on the 15th day of gestational age.